1. Home
  2. ATRC vs CLDX Comparison

ATRC vs CLDX Comparison

Compare ATRC & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$36.74

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$25.68

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATRC
CLDX
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
ATRC
CLDX
Price
$36.74
$25.68
Analyst Decision
Strong Buy
Buy
Analyst Count
9
10
Target Price
$52.22
$44.10
AVG Volume (30 Days)
425.9K
738.8K
Earning Date
02-11-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$518,304,999.00
$2,599,000.00
Revenue This Year
$16.90
N/A
Revenue Next Year
$12.25
$23.23
P/E Ratio
N/A
N/A
Revenue Growth
15.80
N/A
52 Week Low
$28.29
$14.40
52 Week High
$43.18
$30.50

Technical Indicators

Market Signals
Indicator
ATRC
CLDX
Relative Strength Index (RSI) 37.68 44.89
Support Level $38.68 $25.15
Resistance Level $43.18 $28.00
Average True Range (ATR) 1.48 1.22
MACD -0.53 -0.10
Stochastic Oscillator 0.00 18.08

Price Performance

Historical Comparison
ATRC
CLDX

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: